CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Pohlman against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jul 31, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Cell Culture MethodsUCB BIOPHARMADec 23, 2024
Recombinant Proteins Derived From Genus Limulus, And Dna Molecules Encoding SameSEIKAGAKUNov 22, 2024
Methods For Isolating, Culturing, And Genetically Engineering Immune Cell Populations For Adoptive TherapyJUNO THERAPEUTICSOct 29, 2024
Methods Of Associating Genetic Variants With A Clinical Outcome In Patients Suffering From Age-Related Macular Degeneration Treated With Anti-VegfREGENERON PHARMACEUTICALSApr 30, 2024
Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of TranscriptionCHARPENTIERApr 26, 2024
Aav-Mediated Gene Therapy Restoring The Otoferlin GeneCENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRSApr 19, 2024
Transparent Wood And A Method For Its PreparationCELLUTECHMar 7, 2024
Composition For Cleaving A Target Dna Comprising A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein, And Use ThereofTOOLGEN INCORPORATEDMar 1, 2023
Use Of Anti-Pd-1 Antibody In The Treatment Of Patients With Colorectal CancerBRISTOL MYERS SQUIBBJul 26, 2022
Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating CancerMERCK SHARP & DOHMEMay 31, 2022

Top competitors of Pohlman

List of top competitors of Pohlman based on patent oppositions.